Dr. Sheheryar Muhammad is a pharmacist who is specialized in Pharmacotherapy in Silver Spring, Maryland. Patients can reach him at 1500 Forest Glen Rd, Silver Spring or contact him on 301-754-7000. Active license number of Dr. Sheheryar Muhammad is 25227 for Pharmacotherapy in Maryland. Dr. Sheheryar Muhammad is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Sheheryar Muhammad speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Sheheryar Muhammad are as mentioned below.
NPI Number:
1871001396
NPI Enumeration Date:
18 Jan, 2018
NPI Last Update On:
18 Jan, 2018
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Sheheryar Muhammad are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
25227
Maryland
Primary
Critical Care
25227
Maryland
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1500 Forest Glen Rd, Silver Spring, Maryland
Zip:
20910-1460
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Sheheryar Muhammad at 1500 Forest Glen Rd, Silver Spring, Maryland or can call on phone at 301-754-7000.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.